| (+)-Medicarpin |
|
|
|
|
|
|
|
| (-)-(E)-Guggulsterone |
|
|
|
|
|
|
99.19% |
| (-)-(S)-Equol |
|
|
|
|
|
|
99.71% |
| (-)-Erteberel |
|
|
|
|
|
|
99.85% |
| (1S,3R)-GNE-502 |
|
|
|
|
|
|
|
| (E)-4-Hydroxytamoxifen-d5 |
|
|
|
|
|
|
98.28% |
| (E)-4-Hydroxytamoxifen |
|
|
|
|
|
|
97.0% |
| (E)-Broparestrol |
|
|
|
|
|
|
|
| (E)-GW7604 |
|
|
|
|
|
|
|
| (E,E)-GLL398 |
|
|
|
|
|
|
|
| (E/Z)-4-Hydroxytamoxifen |
|
|
|
|
|
|
99.62% |
| (E/Z)-Droloxifene |
|
|
|
|
|
|
98.04% |
| (E/Z)-GSK5182 |
|
|
|
|
|
|
98.90% |
| (E/Z)-Panomifene hydrochloride |
|
|
|
|
|
|
|
| (R)-DPN |
|
|
|
|
|
|
|
| (R)-GDC-0927 |
|
|
|
|
|
|
98.78% |
| (R)-Moxestrol |
|
|
|
|
|
|
|
| (R)-OP-1074 |
|
|
|
|
|
|
98.24% |
| (R)-Equol |
|
|
|
|
|
|
98.68% |
| (R,R)-THC |
|
|
|
|
|
|
99.0% |
| (Rac)-Acolbifene |
|
|
|
|
|
|
98.18% |
| (Rac)-ErSO-DFP |
|
|
|
|
|
|
|
| (Rac)-Hexestrol |
|
|
|
|
|
|
|
| (Rac)-Vepdegestrant |
|
|
|
|
|
|
|
| (Rac)-Hexestrol-d4 |
|
|
|
|
|
|
|
| (Rac)-Hexestrol-d6 |
|
|
|
|
|
|
|
| (Rac)-Hexestrol-d6-1 |
|
|
|
|
|
|
|
| (rel)-PROTAC ERRα Degrader-1 |
|
|
|
|
|
|
98.18% |
| (S)-ErSO |
|
|
|
|
|
|
99.40% |
| (S)-STO021 |
|
|
|
|
|
|
|
| (Z)-Norendoxifen |
|
|
|
|
|
|
|
| (±)-ErSO |
|
|
|
|
|
|
|
| (±)-Isopaucifloral F |
|
|
|
|
|
|
|
| (±)-Equol |
|
|
|
|
|
|
98.03% |
| 10-Chloroestra-1,4-diene-3,17-dione |
|
|
|
|
|
|
|
| 10β,17β-dihydroxyestra-1,4-dien-3-one |
|
|
|
|
|
|
99.37% |
| 14-3-3σ/ERα stabilizer-1 |
|
|
|
|
|
|
|
| 14-3-3σ/ERα stabilizer-2 |
|
|
|
|
|
|
|
| 17-Epiestriol-d5-1 |
|
|
|
|
|
|
|
| 17-Epiestriol |
|
|
|
|
|
|
|
| 17β-Hydroxy exemestane |
|
|
|
|
|
|
|
| 2,3,4-Trihydroxybenzophenone |
|
|
|
|
|
|
99.92% |
| 2,4'-Dihydroxybenzophenone-1 |
|
|
|
|
|
|
99.63% |
| 2-Bromoestradiol |
|
|
|
|
|
|
99.59% |
| 2-Ethylhexyl diphenyl phosphate |
|
|
|
|
|
|
94.27% |
| 2-Hydroxyestrone |
|
|
|
|
|
|
98.15% |
| 2-Hydroxyestrone-13C6 |
|
|
|
|
|
|
|
| 2-Hydroxyestrone-d4 |
|
|
|
|
|
|
97.94% |
| (20S)-Protopanaxatriol |
|
|
|
|
|
|
99.93% |
| 27-Hydroxycholesterol |
|
|
|
|
|
|
99.77% |
| 3'-Hydroxymirificin |
|
|
|
|
|
|
|
| 3,7-Dihydroxyflavone |
|
|
|
|
|
|
98.04% |
| 3-Chlorobisphenol A |
|
|
|
|
|
|
|
| 3-Formylsalicylic acid |
|
|
|
|
|
|
98.46% |
| 4',2-Dihydroxy-4,6-dimethoxydihydrochalcone |
|
|
|
|
|
|
98.0% |
| 4'-Hydroxytamoxifen |
|
|
|
|
|
|
99.2% |
| 4'-Hydroxytamoxifen TFA |
|
|
|
|
|
|
99.43% |
| 4'-Hydroxytamoxifen-d6 (contains up to 10% E isomer) |
|
|
|
|
|
|
|
| 4,4'-(Cyclohexylidenemethylene)diphenol |
|
|
|
|
|
|
|
| 4,4'-Iminodiphenol |
|
|
|
|
|
|
99.01% |
| 4,4'-Oxydiphenol |
|
|
|
|
|
|
|
| 4,4'-Sulfonyldiphenol-d8 |
|
|
|
|
|
|
99.21% |
| 4,7-Dihydroxycoumarin |
|
|
|
|
|
|
98.25% |
| 4-(Ethoxymethyl)phenol |
|
|
|
|
|
|
98.02% |
| 4-Chlorodiphenyl ether |
|
|
|
|
|
|
|
| 4-Chlorodiphenyl ether-d5 |
|
|
|
|
|
|
99.3% |
| 4-Hydroxytoremifene |
|
|
|
|
|
|
|
| 4-Nonylphenol-d5 |
|
|
|
|
|
|
99.22% |
| 4-sec-Butylphenol |
|
|
|
|
|
|
|
| 4-tert-Octylphenol monoethoxylate |
|
|
|
|
|
|
|
| 4-Chlorophenylacetic acid |
|
|
|
|
|
|
99.94% |
| Mequinol |
|
|
|
|
|
|
99.81% |
| 4-Hydroxytamoxifen |
|
|
|
|
|
|
99.86% |
| 4-Hydroxyestrone |
|
|
|
|
|
|
98.77% |
| 4-Hydroxyestrone-13C6 |
|
|
|
|
|
|
|
| 4-Hydroxyestrone-d4 |
|
|
|
|
|
|
99.35% |
| 4'-Raloxifene-β-D-glucopyranoside |
|
|
|
|
|
|
|
| 4H-Chromen-4-one-o-carborane |
|
|
|
|
|
|
|
| 6-Raloxifene-β-D-glucopyranoside |
|
|
|
|
|
|
|
| 6-Dehydronandrolone acetate |
|
|
|
|
|
|
99.94% |
| 7α-(Thiomethyl)spironolactone |
|
|
|
|
|
|
99.80% |
| 7β-Hydroxy-epi-androsterone |
|
|
|
|
|
|
|
| AC-186 |
|
|
|
|
|
|
99.61% |
| Acolbifene |
|
|
|
|
|
|
99.42% |
| Acolbifene hydrochloride |
|
|
|
|
|
|
99.00% |
| ADX61623 |
|
|
|
|
|
|
98.84% |
| ADX68692 |
|
|
|
|
|
|
|
| AhR modulator-1 |
|
|
|
|
|
|
|
| Alpha-Zearalenol-d7 |
|
|
|
|
|
|
|
| Amcenestrant |
|
|
|
|
|
|
99.79% |
| Amsonic acid |
|
|
|
|
|
|
|
| Androgen receptor allosteric antagonist 1 |
|
|
|
|
|
|
|
| Anordiol |
|
|
|
|
|
|
|
| Anticancer agent 276 |
|
|
|
|
|
|
|
| Antiestrogenic agent-1 |
|
|
|
|
|
|
|
| Antiproliferative agent-51 |
|
|
|
|
|
|
|
| Arg-TERRα |
|
|
|
|
|
|
|
| Artonin U |
|
|
|
|
|
|
|
| Arzoxifene |
|
|
|
|
|
|
|
| Arzoxifene hydrochloride |
|
|
|
|
|
|
98.00% |
| AZ'6421 |
|
|
|
|
|
|
98.13% |
| AZD9496 |
|
|
|
|
|
|
99.28% |
| AZD9496 deacrylic acid phenol |
|
|
|
|
|
|
96.56% |
| AZD9496 maleate |
|
|
|
|
|
|
99.35% |
| AZD9496-O-C3-O-C3-O-C-acid |
|
|
|
|
|
|
|
| BAY-184 |
|
|
|
|
|
|
99.00% |
| Bazedoxifene acetate-B |
|
|
|
|
|
|
|
| BE-26263 |
|
|
|
|
|
|
|
| Bexirestrant |
|
|
|
|
|
|
99.26% |
| BHPI |
|
|
|
|
|
|
98.0% |
| Biotin-cholesterol |
|
|
|
|
|
|
97.2% |
| Bisphenol AF-d4 |
|
|
|
|
|
|
|
| Bisphenol B |
|
|
|
|
|
|
99.34% |
| Bisphenol C |
|
|
|
|
|
|
98.0% |
| BMI-135 |
|
|
|
|
|
|
|
| Brilanestrant |
|
|
|
|
|
|
99.85% |
| BY13 |
|
|
|
|
|
|
|
| Camizestrant |
|
|
|
|
|
|
99.32% |
| Cancer-Targeting Compound 1 |
|
|
|
|
|
|
98.37% |
| Carbazole derivative 1 |
|
|
|
|
|
|
|
| CARM1-IN-6 |
|
|
|
|
|
|
99.59% |
| CDD-1274 |
|
|
|
|
|
|
|
| CHEMBL4224880 |
|
|
|
|
|
|
|
| CHF 4227 free base |
|
|
|
|
|
|
|
| Cholesterol (GMP Like) |
|
|
|
|
|
|
|
| CIDD-0149897 |
|
|
|
|
|
|
99.91% |
| CIMBA hydrochloride |
|
|
|
|
|
|
|
| Cimicifuga racemosa extract |
|
|
|
|
|
|
|
| CITFA |
|
|
|
|
|
|
|
| Clomiphene-d5 hydrochloride |
|
|
|
|
|
|
98.53% |
| CMP8 |
|
|
|
|
|
|
|
| Conjugated estrogen sodium |
|
|
|
|
|
|
|
| Corifollitropin alfa |
|
|
|
|
|
|
|
| CS-1-103 |
|
|
|
|
|
|
|
| CS-1-69 |
|
|
|
|
|
|
|
| CV2a |
|
|
|
|
|
|
|
| Cyclodiol |
|
|
|
|
|
|
|
| Cyclofenil |
|
|
|
|
|
|
95.0% |
| Cyproterone |
|
|
|
|
|
|
99.89% |
| D 15413 |
|
|
|
|
|
|
|
| Dehydrodiconiferyl alcohol |
|
|
|
|
|
|
98.32% |
| Desketoraloxifene |
|
|
|
|
|
|
|
| Diethylstilbestrol diphosphate |
|
|
|
|
|
|
|
| Dimestrol |
|
|
|
|
|
|
|
| Diptoindonesin G |
|
|
|
|
|
|
|
| DK1 |
|
|
|
|
|
|
99.69% |
| DK3 |
|
|
|
|
|
|
99.82% |
| DPN |
|
|
|
|
|
|
99.66% |
| Droloxifene |
|
|
|
|
|
|
99.89% |
| DS20362725 |
|
|
|
|
|
|
99.34% |
| DS45500853 |
|
|
|
|
|
|
99.18% |
| DY131 |
|
|
|
|
|
|
99.22% |
| E,E-Dienestrol-d6-1 |
|
|
|
|
|
|
|
| Endoxifen (E-isomer) |
|
|
|
|
|
|
98.02% |
| Endoxifen E-isomer hydrochloride |
|
|
|
|
|
|
98.20% |
| E2-CDS |
|
|
|
|
|
|
|
| EC 313 |
|
|
|
|
|
|
|
| Elacestrant |
|
|
|
|
|
|
99.38% |
| Elacestrant (S enantiomer) |
|
|
|
|
|
|
|
| Elacestrant dihydrochloride |
|
|
|
|
|
|
99.54% |
| Elacestrant S enantiomer dihydrochloride |
|
|
|
|
|
|
|
| Elacestrant-d10 |
|
|
|
|
|
|
|
| Elacestrant-d4 |
|
|
|
|
|
|
|
| Elacestrant-d4-1 |
|
|
|
|
|
|
|
| Elacestrant-d5 |
|
|
|
|
|
|
|
| Elacestrant-d6 |
|
|
|
|
|
|
|
| EM-800 |
|
|
|
|
|
|
|
| EN171 |
|
|
|
|
|
|
98.14% |
| Endoxifen-d5 |
|
|
|
|
|
|
|
| Endoxifen-d5 (Z-isomer) |
|
|
|
|
|
|
|
| ent-Estradiol |
|
|
|
|
|
|
|
| Equilin |
|
|
|
|
|
|
99.79% |
| Equilin-d2 |
|
|
|
|
|
|
|
| ER covalent antagonist-1 |
|
|
|
|
|
|
|
| ER degrader 1 |
|
|
|
|
|
|
|
| ER degrader 10 |
|
|
|
|
|
|
|
| ER degrader 11 |
|
|
|
|
|
|
|
| ER degrader 12 |
|
|
|
|
|
|
|
| ER degrader 13 |
|
|
|
|
|
|
|
| ER degrader 2 |
|
|
|
|
|
|
|
| ER degrader 3 |
|
|
|
|
|
|
|
| ER degrader 4 |
|
|
|
|
|
|
|
| ER degrader 5 |
|
|
|
|
|
|
|
| ER degrader 6 |
|
|
|
|
|
|
|
| ER degrader 7 |
|
|
|
|
|
|
|
| ER degrader 9 |
|
|
|
|
|
|
|
| ER ligand-10 |
|
|
|
|
|
|
|
| ER ligand-11 |
|
|
|
|
|
|
|
| ER ligand-12 |
|
|
|
|
|
|
|
| ER ligand-13 |
|
|
|
|
|
|
|
| ER ligand-14 |
|
|
|
|
|
|
|
| ER ligand-14-PEG3-Boc |
|
|
|
|
|
|
|
| ER ligand-2 |
|
|
|
|
|
|
|
| ER ligand-5 |
|
|
|
|
|
|
|
| ER ligand-6 |
|
|
|
|
|
|
|
| ER ligand-7 |
|
|
|
|
|
|
|
| ER ligand-8 |
|
|
|
|
|
|
|
| ER ligand-9 |
|
|
|
|
|
|
|
| ERB-196 |
|
|
|
|
|
|
99.89% |
| ERB-2 |
|
|
|
|
|
|
|
| ERD-12310A |
|
|
|
|
|
|
|
| ERD-1233 |
|
|
|
|
|
|
|
| ERD-308 |
|
|
|
|
|
|
98.13% |
| ERD-3111 |
|
|
|
|
|
|
98.72% |
| ERRα antagonist-1 |
|
|
|
|
|
|
99.71% |
| ERRα antagonist-2 |
|
|
|
|
|
|
99.07% |
| ERRα ligand 2 |
|
|
|
|
|
|
99.36% |
| ERRγ agonist-1 |
|
|
|
|
|
|
98.02% |
| ERRγ inverse agonist 1 |
|
|
|
|
|
|
|
| ERRγ inverse agonist 2 |
|
|
|
|
|
|
|
| ERRγ-IN-1 |
|
|
|
|
|
|
|
| ErSO |
|
|
|
|
|
|
99.95% |
| ErSO-DFP |
|
|
|
|
|
|
99.56% |
| Erteberel |
|
|
|
|
|
|
99.49% |
| ERα antagonist 1 |
|
|
|
|
|
|
|
| ERα antagonist 2 |
|
|
|
|
|
|
|
| ERα degrader 10 |
|
|
|
|
|
|
|
| ERα degrader 11 |
|
|
|
|
|
|
|
| ERα degrader 12 |
|
|
|
|
|
|
|
| ERα degrader 13 |
|
|
|
|
|
|
|
| ERα degrader 14 |
|
|
|
|
|
|
|
| ERα degrader 4 |
|
|
|
|
|
|
|
| ERα degrader 5 |
|
|
|
|
|
|
|
| ERα degrader 6 |
|
|
|
|
|
|
|
| ERα degrader 7 |
|
|
|
|
|
|
|
| ERα degrader 8 |
|
|
|
|
|
|
|
| ERα degrader 9 |
|
|
|
|
|
|
|
| ERα degrader-2 |
|
|
|
|
|
|
98.30% |
| ERα ligand 3 |
|
|
|
|
|
|
|
| ERα ligand 4 |
|
|
|
|
|
|
|
| ERα ligand 5 |
|
|
|
|
|
|
|
| Erα-IN-1 |
|
|
|
|
|
|
|
| ERα/ERβ antagonist-1 |
|
|
|
|
|
|
|
| ERβ agonist-1 |
|
|
|
|
|
|
|
| ERβ agonist-2 |
|
|
|
|
|
|
|
| Estetrol-d4 (Major) |
|
|
|
|
|
|
|
| Estradiol acetate |
|
|
|
|
|
|
|
| Estradiol cypionate |
|
|
|
|
|
|
99.47% |
| Estradiol enanthate |
|
|
|
|
|
|
98.07% |
| Estradiol hemihydrate |
|
|
|
|
|
|
99.79% |
| Estrogen receptor antagonist 1 |
|
|
|
|
|
|
|
| Estrogen receptor antagonist 2 |
|
|
|
|
|
|
|
| Estrogen receptor antagonist 3 |
|
|
|
|
|
|
|
| Estrogen receptor antagonist 4 |
|
|
|
|
|
|
|
| Estrogen receptor antagonist 5 |
|
|
|
|
|
|
|
| Estrogen receptor antagonist 6 |
|
|
|
|
|
|
|
| Estrogen receptor antagonist 7 |
|
|
|
|
|
|
|
| Estrogen receptor antagonist 8 |
|
|
|
|
|
|
|
| Estrogen receptor antagonist 9 |
|
|
|
|
|
|
|
| Estrogen receptor modulator 1 |
|
|
|
|
|
|
99.91% |
| Estrogen receptor modulator 10 |
|
|
|
|
|
|
|
| Estrogen receptor modulator 11 |
|
|
|
|
|
|
|
| Estrogen receptor modulator 12 |
|
|
|
|
|
|
|
| Estrogen receptor modulator 14 |
|
|
|
|
|
|
|
| Estrogen receptor modulator 6 |
|
|
|
|
|
|
|
| Estrogen receptor modulator 7 |
|
|
|
|
|
|
|
| Estrogen receptor modulator 8 |
|
|
|
|
|
|
|
| Estrogen receptor α antagonist 1 |
|
|
|
|
|
|
|
| Estrogen receptor β antagonist 2 |
|
|
|
|
|
|
98.39% |
| Estrogen receptor β/HDAC probe 1 |
|
|
|
|
|
|
|
| Estrogen receptor-agonist-1 |
|
|
|
|
|
|
99.62% |
| Estrogen receptor-IN-1 |
|
|
|
|
|
|
99.87% |
| Estrone acetate |
|
|
|
|
|
|
|
| Estrone sulfate |
|
|
|
|
|
|
|
| Estrone sulfate potassium |
|
|
|
|
|
|
99.94% |
| Estrone sulfate sodium |
|
|
|
|
|
|
99.84% |
| Estrone sulfate-d4 sodium |
|
|
|
|
|
|
99.38% |
| Estrone sulfate-d4 TEA |
|
|
|
|
|
|
|
| Estrone sulfate-d5 sodium |
|
|
|
|
|
|
|
| Estrone-N-O-C1-amido |
|
|
|
|
|
|
|
| ET receptor antagonist 1 |
|
|
|
|
|
|
|
| ET receptor antagonist 2 |
|
|
|
|
|
|
|
| ET receptor antagonist 3 |
|
|
|
|
|
|
|
| Etacstil |
|
|
|
|
|
|
|
| Ethamoxytriphetol |
|
|
|
|
|
|
|
| Etonogestrel-d6 |
|
|
|
|
|
|
|
| F0840-0093 |
|
|
|
|
|
|
|
| Fenhexamid |
|
|
|
|
|
|
99.60% |
| Fenhexamid-d10 |
|
|
|
|
|
|
|
| FERb 033 |
|
|
|
|
|
|
|
| Ferutinin |
|
|
|
|
|
|
99.23% |
| Fispemifene |
|
|
|
|
|
|
99.67% |
| FLTX1 |
|
|
|
|
|
|
99.75% |
| Fluoroestradiol |
|
|
|
|
|
|
|
| Follitropin alfa, Lutropin alfa (2:1) |
|
|
|
|
|
|
|
| FRAGHIT-4 |
|
|
|
|
|
|
|
| FSH receptor antagonist 1 |
|
|
|
|
|
|
95.0% |
| FSHR agonist 1 |
|
|
|
|
|
|
99.45% |
| Fulvestrant-3-boronic acid |
|
|
|
|
|
|
99.7% |
| G-1 |
|
|
|
|
|
|
99.76% |
| G-1 (Standard) |
|
|
|
|
|
|
|
| G15 |
|
|
|
|
|
|
99.0% |
| G36 |
|
|
|
|
|
|
99.35% |
| Galaxolide-d6 (mixture of diastereomers) (>80%) |
|
|
|
|
|
|
|
| GDC-0927 |
|
|
|
|
|
|
99.98% |
| GDC-0927 Racemate |
|
|
|
|
|
|
|
| Geranium oil |
|
|
|
|
|
|
|
| Giredestrant |
|
|
|
|
|
|
98.98% |
| Giredestrant tartrate |
|
|
|
|
|
|
|
| Glicoricone |
|
|
|
|
|
|
96.0% |
| GLL398 |
|
|
|
|
|
|
|
| Glyceollin I |
|
|
|
|
|
|
|
| GNE-149 |
|
|
|
|
|
|
99.18% |
| GNE-1567 |
|
|
|
|
|
|
|
| GNE-274 |
|
|
|
|
|
|
98.00% |
| GNE-502 |
|
|
|
|
|
|
99.73% |
| GNE-5472 |
|
|
|
|
|
|
|
| GPER activator 1 |
|
|
|
|
|
|
|
| GPER/Bcl-2-IN-1 |
|
|
|
|
|
|
|
| GPR30 agonist-1 |
|
|
|
|
|
|
98.62% |
| GSK-4716 |
|
|
|
|
|
|
99.63% |
| GSK5182 |
|
|
|
|
|
|
99.10% |
| GTX-758 |
|
|
|
|
|
|
99.59% |
| GuaB-IN-1 |
|
|
|
|
|
|
|
| GW7604 |
|
|
|
|
|
|
98.0% |
| H3B-5942 |
|
|
|
|
|
|
98.25% |
| H3B-6545 |
|
|
|
|
|
|
99.44% |
| H3B-6545 hydrochloride |
|
|
|
|
|
|
99.16% |
| Hexestrol |
|
|
|
|
|
|
99.79% |
| Hexolame |
|
|
|
|
|
|
|
| hFSH-β-(33-53) |
|
|
|
|
|
|
|
| hFSH-β-(33-53) TFA |
|
|
|
|
|
|
99.56% |
| HGH fragment 176-191 |
|
|
|
|
|
|
|
| His-TERRα |
|
|
|
|
|
|
|
| HIT-2 |
|
|
|
|
|
|
|
| HMR-3339 |
|
|
|
|
|
|
|
| HSD17B13-IN-94 |
|
|
|
|
|
|
|
| Hydroxytyrosol acetate |
|
|
|
|
|
|
98.10% |
| Icariside D1 |
|
|
|
|
|
|
|
| Imlunestrant |
|
|
|
|
|
|
99.96% |
| Imlunestrant tosylate |
|
|
|
|
|
|
99.68% |
| Indazole-Cl |
|
|
|
|
|
|
98.19% |
| Inokosterone |
|
|
|
|
|
|
|
| Isocurcumenol |
|
|
|
|
|
|
99.47% |
| Isoflavone |
|
|
|
|
|
|
40.0% |
| J 628 |
|
|
|
|
|
|
|
| JNJ-1250132 |
|
|
|
|
|
|
|
| KAT6-IN-4 |
|
|
|
|
|
|
|
| Lactandrate |
|
|
|
|
|
|
|
| Levormeloxifene |
|
|
|
|
|
|
|
| Levormeloxifene fumarate |
|
|
|
|
|
|
|
| Lindleyin |
|
|
|
|
|
|
99.95% |
| LNS8801 |
|
|
|
|
|
|
|
| LSD1/ER-IN-1 |
|
|
|
|
|
|
|
| LSZ-102 |
|
|
|
|
|
|
99.94% |
| Lupinalbin A |
|
|
|
|
|
|
|
| LX-039 |
|
|
|
|
|
|
|
| LY117018 |
|
|
|
|
|
|
99.47% |
| LY117018 TFA |
|
|
|
|
|
|
99.18% |
| LY2066948 |
|
|
|
|
|
|
|
| LY88074 Methyl ether |
|
|
|
|
|
|
|
| LY88074 Trimethyl ether |
|
|
|
|
|
|
|
| Mansonone F |
|
|
|
|
|
|
|
| MC-Val-Cit-PAB-PROTAC ERα Degrader-1 |
|
|
|
|
|
|
99.18% |
| Mepitiostane |
|
|
|
|
|
|
|
| Metahexestrol |
|
|
|
|
|
|
|
| Methylpiperidino pyrazole |
|
|
|
|
|
|
|
| Millewanin G |
|
|
|
|
|
|
|
| MK-6913 |
|
|
|
|
|
|
|
| MK-8389 |
|
|
|
|
|
|
|
| Moracin G |
|
|
|
|
|
|
|
| MPP dihydrochloride |
|
|
|
|
|
|
99.54% |
| MPP hydrochloride |
|
|
|
|
|
|
99.25% |
| Nafoxidine |
|
|
|
|
|
|
98.75% |
| Nafoxidine hydrochloride |
|
|
|
|
|
|
|
| NDC 1308 |
|
|
|
|
|
|
|
| Neo-sagittasine A |
|
|
|
|
|
|
|
| NEP168 |
|
|
|
|
|
|
|
| NKS-01 |
|
|
|
|
|
|
|
| NNC45-0781 |
|
|
|
|
|
|
|
| o,p'-DDT |
|
|
|
|
|
|
|
| OBHS |
|
|
|
|
|
|
|
| OBHSA |
|
|
|
|
|
|
|
| Octinoxate-13C,d3 |
|
|
|
|
|
|
|
| Octocrylene-13C3 |
|
|
|
|
|
|
|
| Octrizole |
|
|
|
|
|
|
99.67% |
| Octrizole-d4 |
|
|
|
|
|
|
|
| OP-1074 |
|
|
|
|
|
|
99.77% |
| OP-1690 |
|
|
|
|
|
|
|
| OP-3136 |
|
|
|
|
|
|
99.90% |
| Org 214444-0 |
|
|
|
|
|
|
|
| Org 43553 |
|
|
|
|
|
|
99.30% |
| Ospemifene-d5 |
|
|
|
|
|
|
|
| OSU-ERβ-12 |
|
|
|
|
|
|
|
| Paclitaxel liposome |
|
|
|
|
|
|
|
| Palazestrant |
|
|
|
|
|
|
99.90% |
| Panomifene |
|
|
|
|
|
|
|
| Paroxetine acetate |
|
|
|
|
|
|
|
| Paroxypropione |
|
|
|
|
|
|
99.97% |
| PBPE hydrochloride |
|
|
|
|
|
|
99.30% |
| PBPE hydrochloride (Standard) |
|
|
|
|
|
|
|
| PELP1-IN-1 |
|
|
|
|
|
|
99.28% |
| Phenolphthalol |
|
|
|
|
|
|
|
| Phthalic acid |
|
|
|
|
|
|
99.94% |
| Phthalic acid-d4 |
|
|
|
|
|
|
98.36% |
| PHTPP |
|
|
|
|
|
|
99.56% |
| PHTPP-1304 |
|
|
|
|
|
|
99.96% |
| Pipendoxifene-d10 |
|
|
|
|
|
|
|
| Prolactin-Releasing Peptide (1-31) (rat) |
|
|
|
|
|
|
|
| Propyl pyrazole triol |
|
|
|
|
|
|
99.11% |
| PROTAC AR Degrader-12 |
|
|
|
|
|
|
|
| PROTAC ER Degrader-10 |
|
|
|
|
|
|
|
| PROTAC ER Degrader-11 |
|
|
|
|
|
|
|
| PROTAC ER Degrader-12 |
|
|
|
|
|
|
|
| PROTAC ER Degrader-14 |
|
|
|
|
|
|
|
| PROTAC ER Degrader-15 |
|
|
|
|
|
|
|
| PROTAC ER Degrader-16 |
|
|
|
|
|
|
|
| PROTAC ER Degrader-2 |
|
|
|
|
|
|
|
| PROTAC ER Degrader-3 |
|
|
|
|
|
|
|
| PROTAC ER Degrader-4 |
|
|
|
|
|
|
98.78% |
| PROTAC ERRα Degrader-1 |
|
|
|
|
|
|
98.22% |
| PROTAC ERRα Degrader-2 |
|
|
|
|
|
|
|
| PROTAC ERRα Degrader-3 |
|
|
|
|
|
|
98.74% |
| PROTAC ERRα ligand 1 |
|
|
|
|
|
|
98.61% |
| PROTAC ERα Degrader-1 |
|
|
|
|
|
|
96.68% |
| PROTAC ERα Degrader-10 |
|
|
|
|
|
|
|
| PROTAC ERα Degrader-11 |
|
|
|
|
|
|
|
| PROTAC ERα Degrader-12 |
|
|
|
|
|
|
|
| PROTAC ERα Degrader-13 |
|
|
|
|
|
|
|
| PROTAC ERα Degrader-2 |
|
|
|
|
|
|
98.92% |
| PROTAC ERα Degrader-4 |
|
|
|
|
|
|
98.63% |
| PROTAC ERα Degrader-6 |
|
|
|
|
|
|
97.55% |
| PROTAC ERα Degrader-7 |
|
|
|
|
|
|
|
| PROTAC ERα Degrader-8 |
|
|
|
|
|
|
|
| PROTAC ERα Degrader-9 |
|
|
|
|
|
|
|
| PROTAC ERα Y537S degrader-1 |
|
|
|
|
|
|
|
| PROTAC_ERRα |
|
|
|
|
|
|
99.71% |
| PSDalpha |
|
|
|
|
|
|
|
| Psidial A |
|
|
|
|
|
|
|
| PVTX-321 |
|
|
|
|
|
|
|
| R4K1 |
|
|
|
|
|
|
|
| Raloxifene |
|
|
|
|
|
|
99.62% |
| Raloxifene 4'-glucuronide |
|
|
|
|
|
|
98.19% |
| Raloxifene 4'-glucuronide-d4 |
|
|
|
|
|
|
|
| Raloxifene 4'-glucuronide-d4 lithium |
|
|
|
|
|
|
|
| Raloxifene 4-Monomethyl Ether |
|
|
|
|
|
|
|
| Raloxifene 6-glucuronide |
|
|
|
|
|
|
|
| Raloxifene 6-glucuronide-d4 lithium |
|
|
|
|
|
|
|
| Raloxifene 6-Monomethyl Ether |
|
|
|
|
|
|
|
| Raloxifene alkene |
|
|
|
|
|
|
|
| Raloxifene dimethyl ester hydrochloride |
|
|
|
|
|
|
|
| Raloxifene-d10 |
|
|
|
|
|
|
|
| Raloxifene-d4 |
|
|
|
|
|
|
|
| Raloxifene-d4 hydrochloride |
|
|
|
|
|
|
98.61% |
| rel-(R,R)-THC |
|
|
|
|
|
|
|
| rel-Erteberel |
|
|
|
|
|
|
|
| Rintodestrant |
|
|
|
|
|
|
99.91% |
| Ripafollitropin alfa (bovine) |
|
|
|
|
|
|
|
| Ro 48-8071 |
|
|
|
|
|
|
99.89% |
| Ro 48-8071 free base |
|
|
|
|
|
|
|
| RU 45144 |
|
|
|
|
|
|
|
| RU-39411 |
|
|
|
|
|
|
|
| RU58668 |
|
|
|
|
|
|
|
| SERT-IN-4 |
|
|
|
|
|
|
|
| SI-2 hydrochloride |
|
|
|
|
|
|
98.06% |
| SLU-PP-1072 |
|
|
|
|
|
|
98.24% |
| SLU-PP-332 |
|
|
|
|
|
|
98.98% |
| Smurf1-IN-A01 |
|
|
|
|
|
|
99.81% |
| SNG-8023 |
|
|
|
|
|
|
|
| SNIPER(ER)-110 |
|
|
|
|
|
|
|
| SNIPER(ER)-87 |
|
|
|
|
|
|
99.2% |
| SR 16234 |
|
|
|
|
|
|
|
| SR-16157 |
|
|
|
|
|
|
|
| SR19881 |
|
|
|
|
|
|
99.30% |
| SRC-1 NR box peptide |
|
|
|
|
|
|
98.18% |
| SRC-1 NR box peptide acetate |
|
|
|
|
|
|
|
| Stilbestrol dipropionate |
|
|
|
|
|
|
|
| STX140 |
|
|
|
|
|
|
|
| Suloxifen |
|
|
|
|
|
|
|
| Tamoxifen analog II |
|
|
|
|
|
|
|
| Tamoxifen Customized Diet |
|
|
|
|
|
|
|
| Tamoxifen-PEG-Clozapine |
|
|
|
|
|
|
|
| Taragarestrant |
|
|
|
|
|
|
|
| Taragarestrant meglumine |
|
|
|
|
|
|
99.33% |
| TCF199 |
|
|
|
|
|
|
|
| TFMB-(R)-2-HG |
|
|
|
|
|
|
98.26% |
| THIQ 40 |
|
|
|
|
|
|
|
| TOP5300 |
|
|
|
|
|
|
|
| TOP5668 |
|
|
|
|
|
|
98.07% |
| Toralactone 9-O-triglucoside |
|
|
|
|
|
|
|
| TPBM |
|
|
|
|
|
|
98.51% |
| Trioxifene |
|
|
|
|
|
|
|
| Trioxifene mesylate |
|
|
|
|
|
|
|
| Triphenylethylene |
|
|
|
|
|
|
99.86% |
| Tschimganidin |
|
|
|
|
|
|
|
| Tschimganin |
|
|
|
|
|
|
|
| TTC-352 |
|
|
|
|
|
|
|
| UT-34 |
|
|
|
|
|
|
98.09% |
| Vepdegestrant |
|
|
|
|
|
|
99.20% |
| VPC-16606 |
|
|
|
|
|
|
|
| WAY-166818 |
|
|
|
|
|
|
|
| WAY-169916 |
|
|
|
|
|
|
99.32% |
| WAY-200070 |
|
|
|
|
|
|
99.57% |
| WAY-214156 |
|
|
|
|
|
|
|
| X15695 |
|
|
|
|
|
|
98.45% |
| XCT790 |
|
|
|
|
|
|
99.67% |
| XOMA-213 |
|
|
|
|
|
|
98.46% |
| Y134 |
|
|
|
|
|
|
99.67% |
| Yp537 |
|
|
|
|
|
|
|
| Yp537 TFA |
|
|
|
|
|
|
|
| Endoxifen (Z-isomer) |
|
|
|
|
|
|
99.19% |
| Endoxifen Z-isomer hydrochloride |
|
|
|
|
|
|
98.98% |
| Zearalenone-13C7 |
|
|
|
|
|
|
|
| Zeranol-d5 (mixture of diastereomers) |
|
|
|
|
|
|
|
| ZINC05925939 |
|
|
|
|
|
|
|
| Zindoxifene |
|
|
|
|
|
|
|
| ZK164015 |
|
|
|
|
|
|
99.94% |
| ZN-c5 |
|
|
|
|
|
|
|
| ZN-c5 hydrochloride |
|
|
|
|
|
|
|
| Zuclomiphene |
|
|
|
|
|
|
|
| Zuclomiphene citrate |
|
|
|
|
|
|
98.92% |
| Zuclomiphene-d4 citrate |
|
|
|
|
|
|
99.0% |
| Zuclomiphene-d5 citrate |
|
|
|
|
|
|
|
| α-Zearalenol |
|
|
|
|
|
|
99.73% |
| α-Zearalenol-d4 |
|
|
|
|
|
|
|
| Zeranol |
|
|
|
|
|
|
98.82% |
| Zeranol-d5-1 |
|
|
|
|
|
|
|
| β-Estradiol 17-acetate |
|
|
|
|
|
|
99.88% |
| Gypenoside XVII |
|
|
|
|
|
|
99.69% |
| Notoginsenoside Ft1 |
|
|
|
|
|
|
99.49% |
| N-Desmethyltamoxifen hydrochloride |
|
|
|
|
|
|
99.63% |
| Ethynyl Estradiol-d4 |
|
|
|
|
|
|
98.95% |
| Estradiol dipropionate |
|
|
|
|
|
|
99.46% |
| Dihydroresveratrol |
|
|
|
|
|
|
99.69% |
| Benzophenone-2 |
|
|
|
|
|
|
99.66% |
| Alternariol |
|
|
|
|
|
|
99.79% |
| Alternariol-d2 |
|
|
|
|
|
|
|
| Tamoxifen-d5 |
|
|
|
|
|
|
99.77% |
| Tamoxifen (Standard) |
|
|
|
|
|
|
99.94% |
| Tamoxifen-13C6 |
|
|
|
|
|
|
|
| Tamoxifen |
|
|
|
|
|
|
99.96% |
| N-Desmethyltamoxifen |
|
|
|
|
|
|
99.59% |
| Tamoxifen-d3 hydrochloride |
|
|
|
|
|
|
98.99% |
| Tamoxifen-d3 |
|
|
|
|
|
|
|
| Etonogestrel |
|
|
|
|
|
|
99.91% |
| Galaxolide |
|
|
|
|
|
|
76.44% |
| Demethylzeylasteral |
|
|
|
|
|
|
99.92% |
| Dienestrol-d2 |
|
|
|
|
|
|
|
| Dienestrol |
|
|
|
|
|
|
98.04% |
| 4,4'-Sulfonyldiphenol |
|
|
|
|
|
|
99.44% |
| (E)-Octinoxate |
|
|
|
|
|
|
98.79% |
| Prochloraz-d7 |
|
|
|
|
|
|
|
| Prochloraz |
|
|
|
|
|
|
99.85% |
| Pipendoxifene |
|
|
|
|
|
|
99.93% |
| Endoxifen |
|
|
|
|
|
|
99.51% |
| Endoxifen hydrochloride |
|
|
|
|
|
|
98.04% |
| (±)-8-Prenylnaringenin |
|
|
|
|
|
|
99.97% |
| Octocrylene |
|
|
|
|
|
|
98.68% |
| Ospemifene |
|
|
|
|
|
|
99.84% |
| Ospemifene-d4 |
|
|
|
|
|
|
99.65% |
| Gestrinone |
|
|
|
|
|
|
99.76% |
| Propylparaben sodium |
|
|
|
|
|
|
99.03% |
| Nilestriol |
|
|
|
|
|
|
98.93% |
| Propylparaben-d4 |
|
|
|
|
|
|
99.62% |
| Propylparaben-d7 |
|
|
|
|
|
|
|
| Kaempferide |
|
|
|
|
|
|
99.80% |
| Kaempferol |
|
|
|
|
|
|
99.92% |
| Kaempferol (Standard) |
|
|
|
|
|
|
99.80% |
| (Z)-Ligustilide |
|
|
|
|
|
|
98.58% |
| Diethylstilbestrol-d8 |
|
|
|
|
|
|
99% |
| Diethylstilbestrol-d3 |
|
|
|
|
|
|
|
| Diethylstilbestrol-d4 |
|
|
|
|
|
|
|
| Diethylstilbestrol |
|
|
|
|
|
|
99.62% |
| Bazedoxifene |
|
|
|
|
|
|
99.06% |
| Bazedoxifene-d4 |
|
|
|
|
|
|
|
| Bazedoxifene-d4 acetate |
|
|
|
|
|
|
|
| Paroxetine-d2 |
|
|
|
|
|
|
|
| Paroxetine-d4 |
|
|
|
|
|
|
|
| Paroxetine-d6-1 |
|
|
|
|
|
|
|
| Paroxetine |
|
|
|
|
|
|
99.66% |
| Enclomiphene |
|
|
|
|
|
|
99.79% |
| Enclomiphene-d4 |
|
|
|
|
|
|
99.85% |
| Enclomiphene citrate |
|
|
|
|
|
|
99.93% |
| Enclomiphene hydrochloride |
|
|
|
|
|
|
|
| Enclomiphene-d4 hydrochloride |
|
|
|
|
|
|
99.0% |
| Estradiol valerate |
|
|
|
|
|
|
99.91% |
| Estradiol valerianate-d4 |
|
|
|
|
|
|
|
| Estradiol valerianate-d9 |
|
|
|
|
|
|
|
| Toremifene-d6 |
|
|
|
|
|
|
|
| Toremifene |
|
|
|
|
|
|
99.73% |
| Toremifene-d6 hydrochloride |
|
|
|
|
|
|
|
| Lasofoxifene |
|
|
|
|
|
|
99.27% |
| Coumestrol |
|
|
|
|
|
|
98.26% |
| Prinaberel |
|
|
|
|
|
|
98.05% |
| Promestriene |
|
|
|
|
|
|
99.91% |
| Tibolone |
|
|
|
|
|
|
99.9% |
| Tibolone-d5 |
|
|
|
|
|
|
|
| Pinoresinol 4-O-β-D-glucopyranoside |
|
|
|
|
|
|
99.89% |
| Tamoxifen Citrate |
|
|
|
|
|
|
99.88% |
| Toremifene-d6 citrate |
|
|
|
|
|
|
|
| Toremifene citrate |
|
|
|
|
|
|
99.88% |
| Clomiphene citrate |
|
|
|
|
|
|
98.22% |
| Genistin |
|
|
|
|
|
|
98.40% |
| Chrysin |
|
|
|
|
|
|
99.75% |
| Saikosaponin D |
|
|
|
|
|
|
99.81% |
| Fulvestrant-d3 |
|
|
|
|
|
|
97.47% |
| Fulvestrant |
|
|
|
|
|
|
99.98% |
| Fulvestrant (R enantiomer) |
|
|
|
|
|
|
|
| Fulvestrant (S enantiomer) |
|
|
|
|
|
|
|
| Chlorotrianisene-d9 |
|
|
|
|
|
|
|
| Chlorotrianisene |
|
|
|
|
|
|
99.02% |
| Clomiphene |
|
|
|
|
|
|
|
| Clomiphene-d5 citrate |
|
|
|
|
|
|
|
| Ethisterone-13C2 |
|
|
|
|
|
|
|
| Ethisterone |
|
|
|
|
|
|
98.02% |
| Ethynyl Estradiol-13C2 |
|
|
|
|
|
|
98.64% |
| Ethinylestradiol |
|
|
|
|
|
|
99.96% |
| Quinestrol |
|
|
|
|
|
|
99.19% |
| Zearalenone |
|
|
|
|
|
|
98.95% |
| (Rac)-Zearalanone-d6 |
|
|
|
|
|
|
|
| Segetalin B |
|
|
|
|
|
|
99.9% |
| Regaloside C |
|
|
|
|
|
|
99.62% |
| Liquiritigenin |
|
|
|
|
|
|
99.59% |
| Liquiritigenin-d4 |
|
|
|
|
|
|
|
| Licoflavone C |
|
|
|
|
|
|
99.83% |
| 2-Ethylhexyl (E)-3-(4-(methoxy-d3)phenyl)acrylate |
|
|
|
|
|
|
|
| Octinoxate |
|
|
|
|
|
|
99.84% |
| Paroxetine mesylate |
|
|
|
|
|
|
|
| Chlorothalonil |
|
|
|
|
|
|
98.15% |
| Pipendoxifene hydrochloride |
|
|
|
|
|
|
99.83% |
| Bazedoxifene hydrochloride |
|
|
|
|
|
|
|
| Paroxetine hydrochloride |
|
|
|
|
|
|
99.98% |
| Clomiphene hydrochloride |
|
|
|
|
|
|
|
| Raloxifene hydrochloride |
|
|
|
|
|
|
99.78% |
| Nitromifene |
|
|
|
|
|
|
|
| Idoxifene |
|
|
|
|
|
|
99.43% |
| Triisopropyl phosphate |
|
|
|
|
|
|
|
| Zuclomiphene d10 Citrate salt |
|
|
|
|
|
|
|
| Tracheloside |
|
|
|
|
|
|
99.77% |
| Mestranol-d2 |
|
|
|
|
|
|
99.0% |
| Mestranol-d4 |
|
|
|
|
|
|
|
| Mestranol |
|
|
|
|
|
|
99.69% |
| Hydroxytyrosol |
|
|
|
|
|
|
98.81% |
| Hydroxytyrosol-d4 |
|
|
|
|
|
|
96.0% |
| Hydroxytyrosol-d5 |
|
|
|
|
|
|
|
| Propylparaben |
|
|
|
|
|
|
99.96% |
| Cholesterol-13C2 |
|
|
|
|
|
|
99.76% |
| Cholesterol-13C3 |
|
|
|
|
|
|
98.80% |
| Cholesterol-d6-1 |
|
|
|
|
|
|
99.82% |
| Cholesterol-d7 |
|
|
|
|
|
|
99.95% |
| Cholesterol (from animal) |
|
|
|
|
|
|
99.94% |
| Cholesterol-13C5 |
|
|
|
|
|
|
99.5% |
| Cholesterol-18O |
|
|
|
|
|
|
|
| Cholesterol-d1 |
|
|
|
|
|
|
99.29% |
| Cholesterol-d4 |
|
|
|
|
|
|
99.26% |
| Cholesterol-d6 |
|
|
|
|
|
|
99.0% |
| rel-Levormeloxifene |
|
|
|
|
|
|
|
| Estradiol benzoate |
|
|
|
|
|
|
99.90% |
| Estradiol benzoate-d3 |
|
|
|
|
|
|
99.0% |
| Bavachin |
|
|
|
|
|
|
99.94% |
| Epi-cryptoacetalide |
|
|
|
|
|
|
|
| Benoxacor |
|
|
|
|
|
|
99.39% |
| Phthalic acid-13C |
|
|
|
|
|
|
|
| Diisopropyl phthalate |
|
|
|
|
|
|
99.37% |
| Diisopropyl phthalate-d4 |
|
|
|
|
|
|
98.8% |
| Lasofoxifene tartrate |
|
|
|
|
|
|
99.93% |
| Dienestrol diacetate |
|
|
|
|
|
|
|
| Bazedoxifene acetate |
|
|
|
|
|
|
99.97% |
| Bazedoxifene acetate-D |
|
|
|
|
|
|
99.88% |
| Avobenzone |
|
|
|
|
|
|
98.0% |
| Avobenzone-13C,d3 |
|
|
|
|
|
|
|
| Avobenzone-d3 |
|
|
|
|
|
|
|
| Estriol |
|
|
|
|
|
|
98.05% |
| Estriol-13C3 |
|
|
|
|
|
|
|
| Estriol-d |
|
|
|
|
|
|
|
| Estriol-d2 |
|
|
|
|
|
|
98.47% |
| Estriol-d3 |
|
|
|
|
|
|
97.57% |
| Estriol-d3-1 |
|
|
|
|
|
|
|
| Estradiol-d2 |
|
|
|
|
|
|
98.03% |
| Estradiol-d4 |
|
|
|
|
|
|
99.12% |
| Estradiol-13C2 |
|
|
|
|
|
|
98.72% |
| Estradiol-13C6 |
|
|
|
|
|
|
|
| Estradiol-d2-1 |
|
|
|
|
|
|
|
| Estradiol-d3 |
|
|
|
|
|
|
98.60% |
| Estradiol-d5 |
|
|
|
|
|
|
|
| Estradiol 3-d3 (β-D-Glucuronide) sodium |
|
|
|
|
|
|
|
| Estradiol |
|
|
|
|
|
|
99.93% |
| Estetrol |
|
|
|
|
|
|
99.76% |
| Estetrol-d3 |
|
|
|
|
|
|
|
| Estetrol-d4 |
|
|
|
|
|
|
97.50% |
| Estrone-13C3 |
|
|
|
|
|
|
98.0% |
| Estrone-d2 |
|
|
|
|
|
|
99.78% |
| Estrone-13C2 |
|
|
|
|
|
|
|
| Estrone-d2-1 |
|
|
|
|
|
|
95.0% |
| Estrone-d4 |
|
|
|
|
|
|
99.54% |
| Estrone |
|
|
|
|
|
|
99.86% |
| Estropipate |
|
|
|
|
|
|
98.72% |
| LY88074 |
|
|
|
|
|
|
99.96% |
| Paroxetine maleate |
|
|
|
|
|
|
99.64% |
| Equilin-d4 |
|
|
|
|
|
|
|
| Tectoridin |
|
|
|
|
|
|
99.52% |